These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12824721)

  • 1. Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
    Kaden JJ; Dempfle CE; Sueselbeck T; Brueckmann M; Poerner TC; Haghi D; Haase KK; Borggrefe M
    Cardiology; 2003; 99(3):140-4. PubMed ID: 12824721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
    Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
    Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.
    Morishita T; Uzui H; Mitsuke Y; Arakawa K; Amaya N; Kaseno K; Ishida K; Nakaya R; Lee JD; Tada H
    J Am Heart Assoc; 2015 Jan; 4(1):e001359. PubMed ID: 25616975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
    Squire IB; Evans J; Ng LL; Loftus IM; Thompson MM
    J Card Fail; 2004 Aug; 10(4):328-33. PubMed ID: 15309700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.
    Hirohata S; Kusachi S; Murakami M; Murakami T; Sano I; Watanabe T; Komatsubara I; Kondo J; Tsuji T
    Heart; 1997 Sep; 78(3):278-84. PubMed ID: 9391291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
    Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
    Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Plasma Matrix Metalloproteinase-3 Levels to Predict Myocardial Infarction in Men With and Without Acute Coronary Syndrome.
    Cavusoglu E; Marmur JD; Kassotis JT; Yanamadala S; Chopra V; Eng C
    Am J Cardiol; 2016 Mar; 117(6):881-6. PubMed ID: 26805660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
    Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
    Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.
    Owolabi US; Amraotkar AR; Coulter AR; Singam NSV; Aladili BN; Singh A; Trainor PJ; Mitra R; DeFilippis AP
    J Thromb Thrombolysis; 2020 Feb; 49(2):235-244. PubMed ID: 31808123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of matrix metalloproteinases activity in acute myocardial infarction.
    Papadopoulos DP; Moyssakis I; Makris TK; Poulakou M; Stavroulakis G; Perrea D; Votteas VE
    Eur Cytokine Netw; 2005 Jun; 16(2):152-60. PubMed ID: 15941687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
    Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
    Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
    Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
    Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
    PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9.
    Zhou L; Kou DQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):297-302. PubMed ID: 30657570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
    Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
    Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
    Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
    J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
    Elmas E; Lang S; Dempfle CE; Kälsch T; Hannak D; Sueselbeck T; Wolpert C; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2007; 45(10):1360-5. PubMed ID: 17727318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.